Work

Reduction in exacerbations with itepekimab in former smokers with chronic obstructive pulmonary disease (COPD) by prior exacerbation frequency

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa3645

Authors: Klaus F. Rabe, Stephanie A Christenson, Arnaud Bourdin, Dave Singh, Nicola Hanania, Amy Praestgaard, Xavier Soler, Michel Djandji, Yamo Deniz, Paul J Rowe, Harry Sacks, Juby Jacob-Nara

Institutions: German Center for Lung Research, LungenClinic Grosshansdorf, University of California, San Francisco, Université de Montpellier, University of Manchester, Manchester University NHS Foundation Trust, Medicines Evaluation Unit, Baylor College of Medicine, Regeneron (United States), Sanofi (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104259

Cites:

Cited by: 1

Related to: 10